Neoadjuvant Dalpiciclib Plus Letrozole for HR+/HER2- Breast Cancer
Clinical trial NCT05512416 · UNKNOWN
Trial details
- NCT number
- NCT05512416
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2023-08-01
- Enrollment
- 35
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.